Hahn H - Search Results

1

The patched polymorphism Pro1315Leu (C3944T) may modulate the association between use of oral contraceptives and breast cancer risk.

Chang-Claude J, Dunning A, Schnitzbauer U, Galmbacher P, Tee L, Wjst M, Chalmers J, Zemzoum I, Harbeck N, Pharoah PD, Hahn H. Chang-Claude J, et al. Among authors: hahn h. Int J Cancer. 2003 Mar 1;103(6):779-83. doi: 10.1002/ijc.10889. Int J Cancer. 2003. PMID: 12516098

2

CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer.

Pharoah PD, Oliveira C, Machado JC, Keller G, Vogelsang H, Laux H, Becker KF, Hahn H, Paproski SM, Brown LA, Caldas C, Huntsman D. Pharoah PD, et al. Among authors: hahn h. Int J Cancer. 2002 Sep 10;101(2):196-7. doi: 10.1002/ijc.10590. Int J Cancer. 2002. PMID: 12209998

3

Unbalanced overexpression of the mutant allele in murine Patched mutants.

Calzada-Wack J, Kappler R, Schnitzbauer U, Richter T, Nathrath M, Rosemann M, Wagner SN, Hein R, Hahn H. Calzada-Wack J, et al. Among authors: hahn h. Carcinogenesis. 2002 May;23(5):727-33. doi: 10.1093/carcin/23.5.727. Carcinogenesis. 2002. PMID: 12016144

4

Analysis of the PTCH coding region in human rhabdomyosarcoma.

Calzada-Wack J, Schnitzbauer U, Walch A, Wurster KH, Kappler R, Nathrath M, Hahn H. Calzada-Wack J, et al. Among authors: hahn h. Hum Mutat. 2002 Sep;20(3):233-4. doi: 10.1002/humu.9056. Hum Mutat. 2002. PMID: 12204003

5

Molecular characterization of Patched-associated rhabdomyosarcoma.

Kappler R, Calzada-Wack J, Schnitzbauer U, Koleva M, Herwig A, Piontek G, Graedler F, Adamski J, Heinzmann U, Schlegel J, Hemmerlein B, Quintanilla-Martinez L, Hahn H. Kappler R, et al. Among authors: hahn h. J Pathol. 2003 Jul;200(3):348-56. doi: 10.1002/path.1361. J Pathol. 2003. PMID: 12845631

6

Transcriptional up-regulation of Gadd45a in Patched-associated medulloblastoma.

Kappler R, Hess I, Schlegel J, Hahn H. Kappler R, et al. Among authors: hahn h. Int J Oncol. 2004 Jul;25(1):113-20. Int J Oncol. 2004. PMID: 15201996

7

Tumor-associated E-cadherin mutations do not induce Wnt target gene expression, but affect E-cadherin repressors.

Laux H, Tomer R, Mader MT, Smida J, Budczies J, Kappler R, Hahn H, Blöchinger M, Schnitzbauer U, Eckardt-Schupp F, Höfler H, Becker KF. Laux H, et al. Among authors: hahn h. Lab Invest. 2004 Oct;84(10):1372-86. doi: 10.1038/labinvest.3700158. Lab Invest. 2004. PMID: 15311212 Free article.

8

A model for PTCH1/Ptch1-associated tumors comprising mutational inactivation and gene silencing.

Uhmann A, Ferch U, Bauer R, Tauber S, Arziman Z, Chen C, Hemmerlein B, Wojnowski L, Hahn H. Uhmann A, et al. Among authors: hahn h. Int J Oncol. 2005 Dec;27(6):1567-75. Int J Oncol. 2005. PMID: 16273213

9

Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma.

Kappler R, Bauer R, Calzada-Wack J, Rosemann M, Hemmerlein B, Hahn H. Kappler R, et al. Among authors: hahn h. Oncogene. 2004 Nov 18;23(54):8785-95. doi: 10.1038/sj.onc.1208133. Oncogene. 2004. PMID: 15480423

10

The patched signaling pathway in tumorigenesis and development: lessons from animal models.

Hahn H, Wojnowski L, Miller G, Zimmer A. Hahn H, et al. J Mol Med (Berl). 1999 Jun;77(6):459-68. doi: 10.1007/s001099900018. J Mol Med (Berl). 1999. PMID: 10475061 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,374 results

Search Page

Filters